[2023.05] Absology signs listing sponsorship agreement with NH Investm…
본문
[Summary] Absolology's three main product lines are ABSOL, a susceptible in vitro immunodiagnostic platform based on various point-of-care diagnostics (POCT) that applies a microfluidics platform, ABSOL-HS, an ultra-sensitive diagnostic platform that can diagnose various heart diseases, degenerative, and traumatic brain diseases, and ABSOL-VET, an animal diagnostic device that can accurately diagnose diseases and measure chronic disease progression in companion animals.
Excerpt from medical observer